Ciprofloxacin-induced immunoglobulin A disease.
Auerbach
Jonathan S
JS
Department of Emergency Medicine and Internal Medicine, King County Hospital Center, State University of New York Downstate, Brooklyn, NY, USA.
Hom
Jeffrey
J
D000890:Anti-Infective Agents / Q000009:adverse effects*; D002648:Child; D002939:Ciprofloxacin / Q000009:adverse effects*; D003875:Drug Eruptions / Q000209:etiology* / Q000276:immunology / Q000473:pathology; D006801:Humans; D007070:Immunoglobulin A / Q000276:immunology*; D008297:Male; D012867:Skin / Q000473:pathology; D012872:Skin Diseases, Vesiculobullous / Q000139:chemically induced* / Q000276:immunology / Q000473:pathology
D000890:Anti-Infective Agents; D007070:Immunoglobulin A; D002939:Ciprofloxacin